The EFPIA (European Federation of Pharmaceutical Industries and Associations) Code constitutes the collection of ethical rules agreed by EFPIA members for the Promotion of Medicinal Products to healthcare professionals (HCPs) and the interactions with HCPs, healthcare organizations (HCOs) and patients’ organizations (POs), with the intent of guaranteeing that these activities are conducted while respecting the most stringent ethical principles of professionalism and responsibility.
The EFPIA Code applies to all types of communication and interaction (traditional and digital). The Code embodies the principles that serve to instill a culture of ethics and integrity needed to guide the industry’s interactions with the healthcare and patient community.
As a member of national associations of pharmaceutical industry, e.g. the Swedish Association of the Pharmaceutical Industry, Lif, BioArctic is committed to follow and maintain the EFPIA Disclosure Code.
BioArctic believes that the collaboration with healthcare professionals is important and contributes to the discovery and development of innovative treatments that improve the lives of patients. BioArctic also believes that interactions shall be performed openly and transparently.
BioArctic conducts research and development of treatments for neurodegenerative diseases and does not currently provide any products on the market.
Publication of transfers of value are made on the following websites:
Sweden https://lif.se/etik/samarbetsdatabaser/